Innovative Procedures
At Makis Health Clinic, we utilize cutting-edge molecular imaging and targeted radionuclide therapies to diagnose and treat cancer at the cellular level. Discover how our theranostic approach maximizes efficacy while minimizing systemic side effects.
Our Core Modalities
Advanced molecular technologies used to map and treat tumors accurately.
PET/CT Imaging
State-of-the-art diagnostic imaging that pairs functional molecular data with anatomical precision, identifying the exact location and extent of cancerous tissue.
Lutetium-177 Therapy
A highly effective targeted radionuclide therapy (e.g., Lu-177 PSMA, Lu-177 DOTATATE) delivering beta radiation exclusively to tumor cells expressing specific molecular targets.
Targeted Alpha Therapy
Employs powerful alpha-emitting isotopes (like Actinium-225) to deliver immense destructive energy over extremely short distances, obliterating cancer cells with minimal collateral damage.
Diagnostic Radiotracers
The core of our theranostic approach. We administer specific radiotracers that act as homing beacons, illuminating cancer receptors to guide subsequent therapeutic interventions.
The Patient Journey
Comprehensive Consultation
Every patient's journey begins with an in-depth review of their medical history and pathology. Our nuclear medicine specialists evaluate your specific tumor markers to determine theranostic candidacy.
Molecular Imaging (See It)
We perform advanced PET/CT scans utilizing highly specific diagnostic radiotracers. This step visually maps your cancer at a cellular level, confirming whether the tumor expresses the necessary receptors for targeted therapy.
Targeted Radionuclide Delivery (Treat It)
If imaging confirms receptor expression, we administer a therapeutic radioisotope via IV infusion. The therapeutic molecules systemically hunt down and bind to the identified cancer cells, delivering localized radiation.
Follow-up & Monitoring
Because our therapies target cancer at the molecular level with minimal damage to healthy tissue, patients often experience fewer side effects. We continue to monitor your progress with follow-up imaging to evaluate treatment efficacy.
Are You a Candidate?
Find out if our advanced molecular imaging and targeted radionuclide therapies are right for your specific diagnosis. Our team is ready to review your case.
Schedule a Case Review